Literature DB >> 8356478

'High-pertension'--the uses of a chronic folk illness for personal adaptation.

S Heurtin-Roberts1.   

Abstract

Chronic illness exerts a lasting and pervasive influence on personal experience of the world. It is commonly viewed as a phenomenon to be coped with, requiring an adaptive response on the part of an individual. Chronic illness, however, is a culturally-influenced tool which in itself can be used to organize and implement an adaptive response to personal experience. Employing Hallowell's concept of the self in the behavioral environment, the uses of a chronic folk illness, 'high-pertension', for personal adaptation are discussed. Data from research on health beliefs about hypertension and illness behavior in a sample of 60 older African-American women in New Orleans are presented. 'High-pertension', a chronic folk illness related to the biomedical 'hypertension', and involving blood and 'nerves', is described. Health beliefs and illness behavior associated with high-pertension are considered as part of an individual's total effort at adaptation within the behavioral environment. These points are made: (1) Chronic illness can be used as a means to express one's self in relation to the behavioral environment. (2) Chronic illness can be used to manipulate and manage the relation of self to environment. (3) Chronic illness can be used to legitimize and announce role change. These uses are available to the individual by virtue of social interaction, cultural precedent and the chronicity and meaning of the illness itself. For persons in a severely stressed, constrained, and disadvantaged social position, as are many older African-American women, chronic illness offers one of the few means of controlling the behavioral environment available to the individual. Although in anthropology and biology we speak of adaptation in terms of human groups, we are ultimately considering person-environment fit, that is, personal adaptation. Chronic illness can be a part of a culturally-influenced adaptive response.

Entities:  

Mesh:

Year:  1993        PMID: 8356478     DOI: 10.1016/0277-9536(93)90260-b

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Idioms of distress revisited.

Authors:  Mark Nichter
Journal:  Cult Med Psychiatry       Date:  2010-06

Review 2.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

Review 3.  Expressions of anxiety in African Americans: ethnography and the epidemiological catchment area studies.

Authors:  S Heurtin-Roberts; L Snowden; L Miller
Journal:  Cult Med Psychiatry       Date:  1997-09

4.  Anthropological approach of adherence factors for antihypertensive drugs.

Authors:  Aline Sarradon-Eck; Marc Egrot; Marie Anne Blance; Muriella Faure
Journal:  Healthc Policy       Date:  2010-05

5.  Violence as a barrier to compliance for the hypertensive urban African American.

Authors:  R L Fong
Journal:  J Natl Med Assoc       Date:  1995-03       Impact factor: 1.798

6.  A community and culture-centered approach to developing effective cardiovascular health messages.

Authors:  Namratha R Kandula; Neerja R Khurana; Gregory Makoul; Sara Glass; David W Baker
Journal:  J Gen Intern Med       Date:  2012-05-15       Impact factor: 5.128

Review 7.  Lay perspectives on hypertension and drug adherence: systematic review of qualitative research.

Authors:  Iain J Marshall; Charles D A Wolfe; Christopher McKevitt
Journal:  BMJ       Date:  2012-07-09

8.  Nasa dugo ('It's in the blood'): lay conceptions of hypertension in the Philippines.

Authors:  Gideon Lasco; Jhaki Mendoza; Alicia Renedo; Maureen L Seguin; Benjamin Palafox; Lia M Palileo-Villanueva; Arianna Maever L Amit; Antonio L Dans; Dina Balabanova; Martin McKee
Journal:  BMJ Glob Health       Date:  2020-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.